Related Experiment Video
Updated: Sep 22, 2025

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage
Published on: August 21, 2021
Targeting the DNA damage response and repair in cancer through nucleotide metabolism
Thomas Helleday1,2, Sean G Rudd1
1Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Abstract:
The exploitation of the DNA damage response and DNA repair proficiency of cancer cells is an important anticancer strategy. The replication and repair of DNA are dependent upon the supply of deoxynucleoside triphosphate (dNTP) building blocks, which are produced and maintained by nucleotide metabolic pathways. Enzymes within these pathways can be promising targets to selectively induce toxic DNA lesions in cancer cells. These same pathways also activate antimetabolites, an important group of chemotherapies that disrupt both nucleotide and DNA metabolism to induce DNA damage in cancer cells. Thus, dNTP metabolic enzymes can also be targeted to refine the use of these chemotherapeutics, many of which remain standard of care in common cancers. In this review article, we will discuss both these approaches exemplified by the enzymes MTH1, MTHFD2 and SAMHD1. © 2022 The Authors. Molecular Oncology published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.
Insights
Targeting nucleotide metabolism enzymes can selectively harm cancer cells by inducing DNA damage. This strategy enhances chemotherapy effectiveness, offering new avenues for cancer treatment.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Cancer cells rely on DNA damage response and repair mechanisms.
- Deoxynucleoside triphosphates (dNTPs) are essential for DNA replication and repair, supplied by nucleotide metabolic pathways.
- Enzymes in nucleotide metabolism are potential targets for cancer therapy.
Purpose of the Study:
- To review strategies targeting deoxynucleoside triphosphate (dNTP) metabolic enzymes for cancer treatment.
- To explore how targeting these enzymes can induce DNA damage in cancer cells.
- To discuss the role of dNTP metabolic enzymes in enhancing chemotherapy.
Main Methods:
- Review of existing literature on DNA damage response, DNA repair, and nucleotide metabolism in cancer.
- Analysis of the role of specific enzymes like MTH1, MTHFD2, and SAMHD1.
- Discussion of antimetabolite chemotherapies and their interaction with nucleotide metabolism.
Main Results:
- Targeting dNTP metabolic enzymes can selectively induce toxic DNA lesions in cancer cells.
- These pathways are crucial for activating antimetabolites, a key class of chemotherapies.
- Enzyme targeting can refine the use of existing chemotherapeutics.
Conclusions:
- Exploiting nucleotide metabolism offers a promising anticancer strategy.
- Targeting enzymes like MTH1, MTHFD2, and SAMHD1 can enhance cancer cell vulnerability.
- This approach holds potential for improving standard cancer care.
More Related Videos
Related Concept Videos
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Overview of DNA Repair
Chemically...
DNA Damage can Stall the Cell Cycle
Base Excision Repair
The first step of...
DNA Damage Can Stall the Cell Cycle
Targeted Cancer Therapies
There are several types of targeted therapies against...

